1. Combination of novel DR5 targeting agonistic scFv antibody TR2-3 with cisplatin shows enhanced synergistic antitumor activity in vitro and in vivo
   Gaoxin Lei et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. Synthetic ligands of death receptor 5 display a cell-selective agonistic effect at different oligomerization levels
   Julien Beyrath et al, 2016, Oncotarget CrossRef
3. Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
   Ali Hassanzadeh et al, 2018, Journal of Cellular Physiology CrossRef
4. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway
   ZHAOJUN WAN et al, 2015, Oncology Reports CrossRef